Efficacy and safety of tenapanor in the management of irritable bowel syndrome with constipation: a systematic review and meta-analysis
Tenapanor is effective in improving IBS-C symptoms but has a higher incidence of treatment-related AEs. Further studies are needed to evaluate its long-term safety.
Authors
- Nikki Duong (ORCID: https://orcid.org/0000-0002-3141-6485)
- Dushyant Singh Dahiya (ORCID: https://orcid.org/0000-0002-8544-9039)
- Islam Mohamed (ORCID: https://orcid.org/0000-0003-3356-4681)
- Ahmed Aref (ORCID: https://orcid.org/0000-0002-4130-7426)
- Hassan Ghoz
- Hazem Abosheaishaa (ORCID: https://orcid.org/0000-0002-5581-8702)
- Ahmed Eltelbany (ORCID: https://orcid.org/0000-0001-8391-426X)
- Mohamed A. Aldemerdash
- Abdallfatah Abdallfatah (ORCID: https://orcid.org/0000-0002-5670-2234)
Institutions
- University of Maryland, Baltimore (US)
- Brooklyn Hospital Center (US)
- University of Kansas (US)
- University of New Mexico (US)
- Beaumont Hospital, Royal Oak (US)
- Beaumont Hospital, Troy (US)
- October 6 University (EG)
- University of Maryland, College Park (US)
- University of Missouri (US)
- Stanford University (US)
- Sohag University (EG)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1097/meg.0000000000003107
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00